The European Prevalence of Resistance Associated Substitutions among Direct Acting Antiviral Failures

<b>Background:</b> Approximately 71 million people are still in need of direct-acting antiviral agents (DAAs). To achieve the World Health Organization Hepatitis C elimination goals, insight into the prevalence and influence of resistance associated substitutions (RAS) is of importance. Collaboratio...

Descripció completa

Dades bibliogràfiques

Autors principals:	Stephanie Popping, Valeria Cento, Carole Seguin-Devaux, Charles A. B. Boucher, Adolfo de Salazar, Eva Heger, Orna Mor, Murat Sayan, Dominique Salmon-Ceron, Nina Weis, Henrik B. Krarup, Robert J. de Knegt, Oana Săndulescu, Vladimir Chulanov, David A. M. C. van de Vijver, Federico García, Francesca Ceccherini-Silberstein
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2021-12-01
Col·lecció:	Viruses
Matèries:	hepatitis C direct-acting antivirals resistance resistance associated substitutions elimination
Accés en línia:	https://www.mdpi.com/1999-4915/14/1/16
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!